cdn mobile

Kerwin Espinosa recants drug trade accusations vs Sen. Leila de Lima

By: Tetch Torres-Tupas - Reporter / @T2TupasINQ - Inquirer.net | April 28,2022 - 06:33 PM

FILE PHOTO: Drug personality Kerwin Espinosa. INQUIRER FILE

MANILA, Philippines —  Self-confessed drug trader Kerwin Espinosa has taken back his allegations that connected Senator Leila De Lima in the business of illegal drugs inside the New Bilibid Prison.

His retraction was contained in a counter-affidavit submitted before the Department of Justice (DOJ) on Thursday.

“Any statement he made against the Senator are false and was the result of pressure, coercion, intimidation, and serious threats to his life and family members from the police who instructed him to implicate the Senator into the illegal drug trade,” the counter-affidavit states.

“For this, undersigned apologizes to Senator De Lima,” adds the legal document signed by Espinosa.

RELATED STORIES

De Lima to Dayan, Espinosa: Admit you don’t know each other

De Lima’s ex-driver belies transporting drug money: Remarks to Pacquiao made ‘under duress’

De Lima to face accuser Kerwin Espinosa in Senate probe

De Lima says Espinosa testimony a very nice script

KGA
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: Cebu Daily News, cebu news, Department of Justice, illegal drugs, Kerwin Espinosa, Senator Leila De Lima
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.